{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:43Z","timestamp":1794002683617,"version":"4.8.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.transci.2023.103853","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:46:37Z","timestamp":1700527597000},"page":"103853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of Therapeutic Apheresis methods in ICU"],"prefix":"10.1016","volume":"63","author":[{"given":"Xanthi","family":"Zikou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derveni","family":"Vaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polychronidou","family":"Vasiliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlorokostas","family":"Panagiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloizos","family":"Stavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2023.103853_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jca.21257","article-title":"Therapeutic plasma exchange: a technical and operational review","volume":"28","author":"Kaplan","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3565(25)08256-4","article-title":"Plasma removal with return of corpuscles","volume":"5","author":"Abel","year":"1914","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.transci.2023.103853_bib3","unstructured":"Tullis J.L. Principles involved in glycerolization and deglycerolization of red cells using the Cohn fractionator. In: Proceedings of a Conference on Plasma Proteins and Cellular Elements of the Blood, November 15, 1954. Cambridge (MA): Protein Foundation, Inc. and the Commission on Plasma Fractionation and Related Processes; 1954. p. 17\u20138."},{"key":"10.1016\/j.transci.2023.103853_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1537-2995.2009.02505.x","article-title":"Therapeutic apheresis: history, clinical application, and lingering uncertainties","volume":"50","author":"McLeod","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103853_bib5","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1039\/D1MA00859E","article-title":"Blood apheresis technologies \u2013 a critical review on challenges towards efficient blood separation and treatment","volume":"2","author":"Bacal","year":"2021","journal-title":"Mater Adv"},{"key":"10.1016\/j.transci.2023.103853_bib6","doi-asserted-by":"crossref","unstructured":"Neubauer H., Kasprowicz N., Rack B. CTCtrap \u2013 Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients. DOI: 10.1055\/s-0034\u20131388519.","DOI":"10.1055\/s-0034-1388519"},{"key":"10.1016\/j.transci.2023.103853_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jca.21265","article-title":"The selective therapeutic apheresis procedures","volume":"28","author":"Sanchez","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000503937","article-title":"Recommendations for therapeutic apheresis by the section \u201cpreparative and therapeutic hemapheresis\u201d of the German society for transfusion medicine and immunohematology","volume":"46","author":"Worel","year":"2019","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1179\/2295333714Y.0000000096","article-title":"The ABC of apheresis","volume":"70","author":"Dierickx","year":"2015","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.transci.2023.103853_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the american society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhanm","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/voxs.12333","article-title":"Automation in blood processing","volume":"12","author":"Ekiaby","year":"2017","journal-title":"ISBT Sci Ser"},{"issue":"9","key":"10.1016\/j.transci.2023.103853_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1371\/journal.pone.0203270","article-title":"Centrifugation-induced release of ATP from red blood cells","volume":"13","author":"Mancuso","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib13","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0887-7963(05)80053-7","article-title":"The mechanisms of leukocyte removal by filtration","volume":"9","author":"Bruil","year":"1995","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2023.103853_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41581-018-0002-x","article-title":"Haemodialysis membranes","volume":"14","author":"Ronco","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1744-9987.1998.tb00078.x","article-title":"Present status of apheresis technologies: part 4. Leukocyte filter","volume":"2","author":"Sueoka","year":"1998","journal-title":"Ther Apher"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib17","article-title":"An introduction to extracorporeal blood purification in critical illness","volume":"21","author":"Lim","year":"2012","journal-title":"Proc Singap Healthc"},{"key":"10.1016\/j.transci.2023.103853_bib18","series-title":"Crit. Care Nephrol.","article-title":"Ronco C (2018) Sorbents: from basic structure to clinical application","author":"Ferrari","year":"2018"},{"key":"10.1016\/j.transci.2023.103853_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-022-06810-1","article-title":"Hemoperfusion in the intensive care unit","volume":"48","author":"Ricci","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04009-w","article-title":"Hemoperfusion: technical aspects and state of the art","volume":"26","author":"Ronco","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib21","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1039\/D1MA00892G","article-title":"A critical review of hemoperfusion adsorbents: materials, functionalization and matrix structure selection","volume":"3","author":"Dou","year":"2022","journal-title":"Mater Adv"},{"key":"10.1016\/j.transci.2023.103853_bib22","first-page":"882","volume":"146","author":"Radomski","year":"2005","journal-title":"J Pharmacol"},{"key":"10.1016\/j.transci.2023.103853_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0169-4332(02)00067-3","volume":"196","author":"Przepiorski","year":"2002","journal-title":"Appl Surf Sci"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.colsurfb.2011.02.019","article-title":"Bilirubin adsorption on amine\/methyl bifunctionalized SBA-15 with platelet morphology","volume":"84","author":"Tang","year":"2011","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.transci.2023.103853_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03353599","article-title":"Bilirubin adsorption property of mesoporous silica and amine-grafted mesoporous silica","volume":"1","author":"Zhang","year":"2009","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.transci.2023.103853_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000468911","article-title":"Extracorporeal sorbent technologies: basic concepts and clinical application","volume":"190","author":"Clark","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transci.2023.103853_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jca.21303","article-title":"The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis","volume":"29","author":"Evers","year":"2014","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2023.103853_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000504144","article-title":"Red blood cells: exchange, transfuse, or deplete","volume":"46","author":"Stussi","year":"2019","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2023.103853_bib30","first-page":"48","article-title":"Red cell exchange in sickle cell disease. Hematology \/ the Education Program of the American Society of Hematology","author":"Swerdlow","year":"2006","journal-title":"Educ Program"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.transci.2023.103853_bib32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1537-2995.2007.01289.x","article-title":"Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning","volume":"47","author":"Worel","year":"2007","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1475-2875-11-158","article-title":"Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study","volume":"11","author":"Auer-Hackenberg","year":"2012","journal-title":"Malar J"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.blre.2012.01.003","article-title":"Hyperleukocytosis, leukostasis and leukapheresis: practice management","volume":"26","author":"Ganzel","year":"2012","journal-title":"Blood Rev"},{"issue":"1\u20132","key":"10.1016\/j.transci.2023.103853_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009053534","article-title":"Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management","volume":"39","author":"Porcu","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.transci.2008.09.001","article-title":"World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry","volume":"39","author":"Witt","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2023.103853_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2147\/JBM.S312140","article-title":"Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients \u2013 a dual-center retrospective cohort study","volume":"12","author":"Rinaldi","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.transci.2023.103853_bib38","doi-asserted-by":"crossref","unstructured":"Panch S.R. and Klein H.G. in Hematology (Seventh Edition), 2018; 1781\u20131791.","DOI":"10.1016\/B978-0-323-35762-3.00118-9"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jca.21332","article-title":"Out with the bad and in with the good; red cell exchange, white cell reduction, and platelet reduction","volume":"29","author":"Marques","year":"2014","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib40","article-title":"Plasmapheresis and other extracorporeal filtration techniques in critical patients","volume":"41","author":"Ruiz","year":"2017","journal-title":"Med Intensiv"},{"key":"10.1016\/j.transci.2023.103853_bib41","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3390\/jcm12082876","article-title":"Indications and outcomes of patients receiving therapeutic plasma exchange under critical care conditions: a retrospective eleven-year single-center study at a tertiary care center","volume":"12","author":"Ring","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.transci.2023.103853_bib42","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.transci.2023.103853_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0885066604271394","article-title":"Use of cellular and plasma apheresis in the critically ill patient: Part 1: Technical and physiological considerations","volume":"20","author":"Linenberger","year":"2005","journal-title":"J Intensive Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2023.103853_bib44","first-page":"38S","article-title":"Plasma and plasma derivatives in therapeutic plasmapheresis","volume":"52","author":"McLeod","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103853_bib45","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jca.1025","article-title":"Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytogenic purpura.","volume":"16","author":"Reutter","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib46","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","article-title":"Plasma exchange in the intensive care unit: a narrative review","volume":"48","author":"Bauer","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jca.21703","article-title":"Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange","volume":"34","author":"Irani","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib48","first-page":"305","article-title":"Plasmapheresis: its effect on toxic agents and drugs","volume":"5","author":"Sketris","year":"1984","journal-title":"Plasma Ther Transfus Technol"},{"key":"10.1016\/j.transci.2023.103853_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/pharmaceutics12050395","article-title":"Is antimicrobial treatment effective during therapeutic plasma exchange? Investigating the role of possible interactions","volume":"12","author":"Krzych","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.transci.2023.103853_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jca.10041","article-title":"Plasma exchange: Why we do what we do","volume":"17","author":"Brecher","year":"2002","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bjae.2018.09.006","article-title":"Pharmacokinetics in sepsis","volume":"19","author":"Charlton","year":"2019","journal-title":"BJA Educ"},{"key":"10.1016\/j.transci.2023.103853_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transci.2023.103853_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ndt\/gfg1051","article-title":"Blood puri\ufb01cation in the intensive care unit","volume":"18","author":"Ponikvar","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transci.2023.103853_bib54","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s13054-020-03241-6","article-title":"The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single center experience","volume":"24","author":"Keith","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12959-019-0198-4","article-title":"Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease","volume":"17","author":"Chang","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.transci.2023.103853_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/2050312119835043","article-title":"Sepsis: the evolution in definition, pathophysiology, and management","volume":"7","author":"Gyawali","year":"2019","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.transci.2023.103853_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00134-020-06339-1","article-title":"Adjuvant therapeutic plasma exchange in septic shock","volume":"47","author":"David","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2253-14-24","article-title":"Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients","volume":"14","author":"Hadem","year":"2014","journal-title":"BMC Anesth"},{"key":"10.1016\/j.transci.2023.103853_bib59","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00134-002-1428-x","article-title":"Is there a role for plasmapheresis\/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know \u2013 but perhaps we are closer","volume":"28","author":"Carcillo","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fmed.2018.00091","article-title":"The role of plasma transfusion in massive bleeding: protecting the endothelial glycocalyx?","volume":"5","author":"Barelli","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.transci.2023.103853_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.transci.2023.103853_bib62","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomized, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jca.22027","article-title":"Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster\u2010randomized controlled trial","volume":"38","author":"Luo","year":"2023","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2023.103853_bib64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s13054-014-0699-2","article-title":"The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta\u2010analysis","volume":"18","author":"Rimmer","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13054-020-02943-1","article-title":"Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure","volume":"24","author":"Honore","year":"2020","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106273","article-title":"Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives","volume":"57","author":"Memish","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bjh.16890","article-title":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients","volume":"190","author":"Zhang","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib68","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13054-020-03171-3","article-title":"Plasma exchange in critically ill COVID-19 patients","volume":"24","author":"Morath","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib69","article-title":"The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure","volume":"8","author":"Keith","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.transci.2023.103853_bib70","doi-asserted-by":"crossref","unstructured":"Kamran S.M., Mirza Z.H., Naseem A. et al., Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study. PLoS ONE 16(1): e0244853.","DOI":"10.1371\/journal.pone.0244853"},{"key":"10.1016\/j.transci.2023.103853_bib71","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.transci.2023.103853_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transci.2023.103853_bib73","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s13054-020-03309-3","article-title":"TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?","volume":"24","author":"Honore","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2022.103433","article-title":"Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome","volume":"61","author":"Beraud","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.transci.2023.103853_bib75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1525-139X.2011.01034.x","article-title":"Beyond dialysis: current and emerging blood puri\ufb01cation techniques","volume":"25","author":"Stegmayr","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.transci.2023.103853_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000439238","article-title":"New options of apheresis in renal diseases: how and when?","volume":"41","author":"Korsak","year":"2016","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib77","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s10157-010-0282-3","article-title":"Successful treatment of HCV related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy","volume":"14","author":"Namba","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transci.2023.103853_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/039139888500800312","article-title":"Efficacy of discontinuous flow centrifugation compared with cascade filtration in Waldenstrom\u2019s macroglobulinemia: a pilot study","volume":"8","author":"Valbonesi","year":"1985","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.transci.2023.103853_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1526-0968.2001.00357.x","article-title":"Current topics on cryofiltration technologies","volume":"5","author":"Siami","year":"2001","journal-title":"Ther Apher"},{"key":"10.1016\/j.transci.2023.103853_bib80","first-page":"463","article-title":"Cryogel studies for the optimization of cryofiltration (CF) therapy","volume":"29","author":"Katsume","year":"1983","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/j.transci.2023.103853_bib81","doi-asserted-by":"crossref","unstructured":"Rockx M.A. and Clark W.F. Plasma exchange for treating cryoglobulinemia: a descriptive analysis. Transfus Apher Sci 42:247\u2013251.","DOI":"10.1016\/j.transci.2010.03.001"},{"key":"10.1016\/j.transci.2023.103853_bib82","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jca.2920040405","article-title":"Uncontrolled trial of cryofiltration in rheumatoid arthritis","volume":"4","author":"Malchesky","year":"1988","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2023.103853_bib83","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1744-9987.2007.00418.x","article-title":"A case report of the therapeutic effect of cryofiltration in a patient with glucocorticoid-resistant ulcerative colitis","volume":"11","author":"Ohkawara","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2023.103853_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1744-9987.2011.01004.x","article-title":"Cryofiltration in the treatment of cryoglobulinemia and HLA antibody incompatible transplantation","volume":"16","author":"Sinha","year":"2012","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2023.103853_bib85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000468911","article-title":"Extracorporeal Sorbent Technologies: Basic Concepts and Clinical Application","volume":"190","author":"Clark","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transci.2023.103853_bib86","doi-asserted-by":"crossref","unstructured":"Klinkmann G., Altrichter J., Reuter D.A. et al. Therapeutic apheresis in sepsis. https:\/\/doi.org\/10.1111\/1744\u20139987.13815.","DOI":"10.1111\/1744-9987.13815"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib87","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/JDRNTRUHS.JDRNTRUHS_94_19","article-title":"Hemoperfusion in the management of acute poisoning","volume":"9","author":"Mahesh","year":"2020","journal-title":"J Dr NTR Univ Health Sci"},{"key":"10.1016\/j.transci.2023.103853_bib88","first-page":"483","article-title":"CRRT for sepsis-induced acute kidney injury","volume":"24","author":"Romagnoli","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib89","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","article-title":"Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls","volume":"22","author":"Ankawi","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib90","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.3390\/ijms221910238","article-title":"Renal replacement techniques in septic shock","volume":"22","author":"Hellman","year":"2021","journal-title":"Mol Sci"},{"key":"10.1016\/j.transci.2023.103853_bib91","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/j.ajkd.2003.11.006","article-title":"Renal replacement therapy with high cut-off hemo\ufb01lters: Impact of convection and diffusion on cytokine clearances and protein status","volume":"43","author":"Morgera","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2023.103853_bib92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000446978","article-title":"Hemodialysis with high cut-off hemodialyzers in patients with multi-drug resistant gram-negative sepsis and acute kidney injury: a retrospective, case-control study","volume":"42","author":"Chelazzi","year":"2016","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib93","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/CCM.0000000000003350","article-title":"A double-blind randomized controlled trial of high cutoff versus standard hemo\ufb01ltration in critically ill patients with acute kidney injury","volume":"46","author":"Atan","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5301\/ijao.5000527","article-title":"High Cut-off hemo\ufb01ltration versus standard hemo\ufb01ltration: effect on plasma cytokines","volume":"39","author":"Atari","year":"2016","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.transci.2023.103853_bib95","article-title":"Extracorporeal haemoadsorption: does the evidence support its routine use in critical care?","author":"Supady","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.transci.2023.103853_bib96","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2023.103853_bib97","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1016\/j.transci.2023.103853_bib98","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.transci.2023.103853_bib99","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","article-title":"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial","volume":"44","author":"Klein","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5492\/wjccm.v9.i1.1","article-title":"Experience with hemoadsorption (CytoSorb) in the management of septic shock patients","volume":"9","author":"Mehta","year":"2020","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib101","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: a case series","volume":"21","author":"Kogelmann","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib102","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10047-017-0967-4","article-title":"Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study","volume":"20","author":"Friesecke","year":"2017","journal-title":"J Artif Organs"},{"key":"10.1016\/j.transci.2023.103853_bib103","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-021-00905-6","article-title":"Can the cytokine adsorber CytoSorb help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis","author":"Scharf","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.transci.2023.103853_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187015","article-title":"The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial","volume":"12","author":"Sch\u00e4dler","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2023.103853_bib105","first-page":"959","article-title":"cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial","volume":"145","author":"Diab","year":"2022","journal-title":"Circulation 2022"},{"key":"10.1016\/j.transci.2023.103853_bib106","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/CCM.0000000000005493","article-title":"CytoSorb rescue for COVID-19 patients with vasoplegic shock and multiple organ failure: a prospective, open-label, randomized controlled pilot study","volume":"50","author":"Stockmann","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2023.103853_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.resuscitation.2022.02.001","article-title":"Cytokine adsorption in patients with post-cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER)\u2014a single-centre, open-label, randomized controlled trial","volume":"173","author":"Supady","year":"2022","journal-title":"Resuscitation"},{"key":"10.1016\/j.transci.2023.103853_bib108","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial","volume":"9","author":"Supady","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.transci.2023.103853_bib109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","article-title":"Efficacy of CytoSorb: a systematic review and meta-analysis","volume":"27","author":"Becker","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1744-9987.2010.00825.x","article-title":"Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column","volume":"14","author":"Huang","year":"2010","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2023.103853_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.672260","article-title":"Case series: efficacy and safety of hemoadsorption with HA-330 adsorber in septic pediatric patients with cancer","author":"Sazonov","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.transci.2023.103853_bib112","first-page":"1","article-title":"Heparin 2.0: a new approach to the infection crisis","volume":"50","author":"Seffer","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib113","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13054-022-04044-7","article-title":"Safety and efficacy of the Seraph\u00ae 100 Microbind\u00ae Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study","volume":"26","author":"Eden","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib114","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2215\/CJN.02560319","article-title":"Extracorporeal removal of poisons and toxins","volume":"14","author":"King","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2023.103853_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1191\/0748233703th171oa","article-title":"Effect of hemoperfusion on plasma paraquat concentration in vivo and in vitro.","volume":"19","author":"Hong","year":"2003","journal-title":"Toxicol Ind Health"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2023.103853_bib116","first-page":"53","article-title":"Use of charcoal hemoperfusion in 55 poisoning","volume":"1","author":"Mydilik","year":"1983","journal-title":"Life Support Syst"},{"issue":"17","key":"10.1016\/j.transci.2023.103853_bib117","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.12998\/wjcc.v11.i17.3932","article-title":"Liver replacement therapy with extracorporeal blood purification techniques current knowledge and future directions","volume":"11","author":"Papamichalis","year":"2023","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.transci.2023.103853_bib118","doi-asserted-by":"crossref","unstructured":"Zhunussov A., Kokoshko A., Kanafina S. Hemoperfusio combined with hamodiafiltration in patient with acute hepatitis B and acute kidney injury. 2022, DOI:https:\/\/doi.org\/10.1016\/j.ekir.2022.01.198.","DOI":"10.1016\/j.ekir.2022.01.198"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib119","article-title":"Extracorporeal hemoperfusion as a potential therapeutic option for severe COVID-19 patients; a narrative review","volume":"8","author":"Safari","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.transci.2023.103853_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2021.100937","article-title":"Hemoperfusion as a therapeutic method for patients with severe COVID-19: a retrospective study","author":"Soleimani","year":"2021","journal-title":"New Microbes N Infect"},{"key":"10.1016\/j.transci.2023.103853_bib121","unstructured":"F.D.A., CytoSorb 300 mL Device Approved by FDA for Emergency Treatment of COVID-19, FDA, Silver Spring, MD, USA, 2020."},{"key":"10.1016\/j.transci.2023.103853_bib122","first-page":"5","article-title":"Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection","author":"Alberici","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transci.2023.103853_bib123","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000511725","article-title":"Hemoperfusion with CytoSorb as adjuvant therapy in critically Ill patients with SARS-CoV2 pneumonia","volume":"50","author":"Rampino","year":"2021","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.202011-4140LE","article-title":"Longitudinal cytokine profiling in patients with severe COVID-19 on extracorporeal membrane oxygenation and hemoadsorption","volume":"203","author":"Lebreton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.transci.2023.103853_bib125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13054-021-03597-3","article-title":"Hemofiltration with the Seraph\u00ae 100 Microbind\u00ae Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients","volume":"25","author":"Kielstein","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib126","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s13054-020-03398-0","article-title":"Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19","volume":"24","author":"Bermejo-Martin","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib127","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/jmv.26876","article-title":"Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019","volume":"93","author":"Tang","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2023.103853_bib128","article-title":"SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes","author":"Jacobs","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2023.103853_bib129","doi-asserted-by":"crossref","unstructured":"Rifkin B.S., Stewart I.J. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series. Blood Purif DOI: 10.1159\/000517430.","DOI":"10.1159\/000517430"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib130","article-title":"A multicenter evaluation of the seraph 100 microbind affinity blood filter for the treatment of severe COVID-19","volume":"4","author":"Chitty","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.transci.2023.103853_bib131","doi-asserted-by":"crossref","unstructured":"Achleitner M., Steenblock C., Danhardt J. et al., Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and in\ufb02ammation following therapeutic apheresis. Molecular Psychiatry, https:\/\/doi.org\/10.1038\/s41380\u2013023-02084\u20131.","DOI":"10.1038\/s41380-023-02084-1"},{"key":"10.1016\/j.transci.2023.103853_bib132","article-title":"Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: a single-centre experience in China","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.transci.2023.103853_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220444","article-title":"Endotoxin and cytokine reducing properties of the oxiris membrane in patients with septic shock: a randomized crossover double-blind study","volume":"14","author":"Broman","year":"2019","journal-title":"PLoS One"},{"issue":"3839","key":"10.1016\/j.transci.2023.103853_bib134","first-page":"44","article-title":"The application value of oxiris-endotoxin adsorption in sepsis","volume":"13","author":"Zhai","year":"2021","journal-title":"Am J Transl Res"},{"issue":"Suppl. 3","key":"10.1016\/j.transci.2023.103853_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000499510","article-title":"Oxiris use in septic shock: experience of two french centres","volume":"47","author":"Schwindenhammer","year":"2019","journal-title":"Blood Purif"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib136","first-page":"1","article-title":"Continuous renal replacement therapy with the adsorbing filter oxiris in septic patients: a case series","volume":"47","author":"Turani","year":"2019","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.transci.2023.103853_bib138","first-page":"1","article-title":"Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID- 19 patients","author":"Premu\u02c7zi V","year":"2021","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2023.103853_bib139","first-page":"1","article-title":"The absorbing filter Oxiris in severe coronavirus disease 2019 patients: a case series","volume":"00","author":"Zhang","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2023.103853_bib140","article-title":"Extracorporeal blood purification in moderate and severe COVID-19 patients: a prospective cohort study","author":"Rosalia","year":"2021","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2023.103853_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.817793","article-title":"Continuous renal replacement therapy with oXiris filter may not be an effective resolution to alleviate cytokine release syndrome in non- AKI patients with severe and critical COVID-19","volume":"13","author":"Kang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transci.2023.103853_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003536","article-title":"Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomized controlled clinical trial","volume":"4","author":"Livigni","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.transci.2023.103853_bib143","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","article-title":"High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomized clinical trial","volume":"47","author":"Garbero","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.transci.2023.103853_bib144","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-0968.2002.00429.x","article-title":"Plasma adsorption in critical care","volume":"6","author":"Yang","year":"2002","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/shk.0b013e31804f5921","article-title":"A novel selective extracorporeal intervention in sepsis: Immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a","volume":"28","author":"Schefold","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.transci.2023.103853_bib146","doi-asserted-by":"crossref","unstructured":"Yao J., Li S., Zhou L. et al. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure. 2019, https:\/\/doi.org\/10.1002\/jca.21690.","DOI":"10.1002\/jca.21690"},{"issue":"6","key":"10.1016\/j.transci.2023.103853_bib147","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1159\/000513161","article-title":"Efficiency of double plasma molecular absorption system on the acute severe cholestatic hepatitis","volume":"50","author":"Wu","year":"2021","journal-title":"Blood Purif"},{"issue":"4","key":"10.1016\/j.transci.2023.103853_bib148","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/cc2895","article-title":"Equipment review: the molecular adsorbents recirculating system (MARS)","volume":"8","author":"Boyle","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2023.103853_bib149","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/039139889601901109","article-title":"A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient\u2019s blood and a bioartificial liver","volume":"19","author":"Stange","year":"1996","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.transci.2023.103853_bib150","series-title":"Molecular Absorbent Recirculating System. National Library of Medicine","author":"Yarrarapu","year":"2023"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:56:42Z","timestamp":1761469002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050223002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1473050223002744"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103853","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Therapeutic Apheresis methods in ICU","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103853"}}